SR

Shallu Rani

Active Director Director DIN 09798105
DIN 09798105 First appointment Nov 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value •••• Premium profile

About Shallu Rani

Data last updated:

Shallu Rani is a Director at Riqfame Critical Care Private Limited (since 2022). The company operates in Chemicals. Riqfame Critical Care Private Limited reported revenue of ₹1.24 Cr (FY 2025).

DIN 09798105
Primary Designation Director
Industry Chemicals
First Appointment 21 Nov 2022
Oldest Company Age 3 yrs
Largest company Riqfame Critical Care Private Limited · ₹1.24 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Nov 20222022₹1.24 Cr (FY 2025)Active

Board colleagues of Shallu Rani

NameDINCompanyDesignation
Pratul Chauhan09783768Riqfame Critical Care Private LimitedDirector

Directorship timeline

Open interactive timeline →
Riqfame Critical Care Private Limited
Premium access

Shareholding and investment profile for Shallu Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shallu Rani

Shallu Rani currently holds 1 directorship: Riqfame Critical Care Private Limited (Director, since 21 Nov 2022, revenue ₹1.24 Cr (FY 2025)).

Shallu Rani was first appointed on 21 Nov 2022 as Director at Riqfame Critical Care Private Limited.

The current boards of Shallu Rani's companies include Pratul Chauhan (Riqfame Critical Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available